FDA approves first new drug developed for postpartum depression - STAT

FDA approves first new drug developed for postpartum depression - STAT

FDA approves first new drug developed for women with postpartum depression

By ADAM FEUERSTEIN

ADOBE

The FDA approved brexanolone, the first drug specifically targeted to treat postpartum depression — the most common complication of childbirth.

READ MORE